Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Study to Investigate the Cardiovascular Effects of Lasmiditan in Healthy Elderly Subjects

Trial Profile

A Study to Investigate the Cardiovascular Effects of Lasmiditan in Healthy Elderly Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Jun 2018

At a glance

  • Drugs Lasmiditan (Primary)
  • Indications Migraine
  • Focus Pharmacodynamics
  • Sponsors Eli Lilly
  • Most Recent Events

    • 30 May 2018 Status changed from active, no longer recruiting to completed.
    • 13 Apr 2018 Status changed from recruiting to active, no longer recruiting.
    • 19 Mar 2018 Planned End Date changed from 1 Mar 2018 to 1 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top